HIV-Related Atherosclerosis: State-of-the-Art-Review.

Humans HIV HIV Infections / complications Antiretroviral Therapy, Highly Active Quality of Life

Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 28 04 2023
accepted: 07 05 2023
medline: 23 10 2023
pubmed: 13 5 2023
entrez: 12 5 2023
Statut: ppublish

Résumé

The infection caused by the Human Immunodeficiency Virus (HIV) has spread rapidly across the globe, assuming the characteristics of an epidemic in some regions. Thanks to the introduction of antiretroviral therapy into routine clinical practice, there was a considerable breakthrough in the treatment of HIV, that is now HIV is potentially well-controlled even in low-income countries. To date, HIV infection has moved from the group of life-threatening conditions to the group of chronic and well controlled ones and the quality of life and life expectancy of HIV

Identifiants

DOI: 10.1016/j.cpcardiol.2023.101783 PMID: 37172874
pubmed: 37172874
pii: S0146-2806(23)00200-1
doi: 10.1016/j.cpcardiol.2023.101783
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101783

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known any competing financial interests or personal relationships that could have appeared to influence the work reported in this statement.

Auteurs

Ashot Avagimyan (A)

Assistant Professor, Anatomical Pathology and Clinical Morphology Department, Yerevan State Medical University after M. Heratsi, Yerevan, Armenia. Electronic address: dr.ashotavagimyan@gmail.com.

Nana Pogosova (N)

Professor, Deputy of General Director for Science and Preventive Cardiology, National Medical Research Centre of Cardiology after E. Chazov, Moscow, Russia.

Lev Kakturskiy (L)

Professor, Scientific Director, Research Institute of Human Morphology FSBI «Petrovskiy NRCS, Moscow, Russia.

Mohammad Sheibani (M)

Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Razi Drug Research Centre, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Olga Urazova (O)

Professor, Head of Pathophysiology Department, Siberian State Medical University, Tomsk, Russia.

Artem Trofimenko (A)

Associate Professor, Pathophysiology Department, Kuban State Medical University, Krasnodar, Russia.

Grizelda Navarsdyan (G)

Professor, Pathophysiology Department, Yerevan State Medical University after M. Heratsi, Yerevan, Armenia.

Zinaida Jndoyan (Z)

Professor, Head of Internal Diseases Propedeutics Department, Yerevan State Medical University after M. Heratsi, Armenia.

Kristina Abgaryan (K)

Associate Professor, Medical Microbiology Department, Yerevan State Medical University after M.Heratsi, Armenia.

Federica Fogacci (F)

Research Fellow, Atherosclerosis and Metabolic Disorders Research Unit, University of Bologna, Bologna, Italy.

Mattia Galli (M)

Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.

Luciano Agati (L)

Professor of Cardiology Department, Head of Cardiology Unit Azienda Policlinico Umberto II, Sapienza University, Rome, Italy.

Zhanna Kobalava (Z)

Professor, Head of Internal Disease, Cardiology and Clinical Pharmacology Department, Peoples' Friendship University of Russia (RUDN), Moscow, Russia.

Davood Shafie (D)

Isfahan Cardiovascular Research Institute, Isfahan, Iran.

Mario Marzilli (M)

Professor, Head of Cardiovascular Medicine Division, University of Pisa, Pisa, Italy.

Liana Gogiashvili (L)

Professor, Head of Experimental and Clinical Pathology Department, Al. Natishvili Institute of Experimental Morphology, I. Javakhishvili Tbilisi State University, Tbilisi, Georgia.

Nizal Sarrafzadegan (N)

Professor, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › HIV-Related Atherosclerosis: State-of-the-Art-Review.
questionsmedicales.fr › Virus › Virus à ARN › Retroviridae › Lentivirus › Lentivirus des primates › VIH (Virus de l'Immunodéficience Humaine) › HIV-Related Atherosclerosis: State-of-the-Art-Review.
questionsmedicales.fr › Maladies du système immunitaire › Déficits immunitaires › Infections à VIH › HIV-Related Atherosclerosis: State-of-the-Art-Review.
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Association de médicaments › Thérapie antirétrovirale hautement active › HIV-Related Atherosclerosis: State-of-the-Art-Review.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › HIV-Related Atherosclerosis: State-of-the-Art-Review.